111 (NASDAQ:YI) Trading Down 1.1% – What’s Next?

111, Inc. Sponsored ADR (NASDAQ:YI) shares were down 1.1% during trading on Wednesday . The company traded as low as $3.49 and last traded at $3.51. Approximately 5,615 shares changed hands during trading, an increase of 92% from the average session volume of 2,926 shares. The stock had previously closed at $3.55.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded 111 from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, 111 has an average rating of “Sell”.

111 Stock Down 1.1%

The firm has a market cap of $30.85 million, a PE ratio of -2.51 and a beta of 0.67. The firm’s 50 day moving average is $3.95 and its 200-day moving average is $5.67.

Insider Buying and Selling

In other 111 news, Director Jian David Sun sold 111,100 shares of the business’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $0.23, for a total value of $25,553.00. Following the completion of the transaction, the director directly owned 472,011 shares in the company, valued at approximately $108,562.53. The trade was a 19.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 595,540 shares of company stock valued at $141,105. 43.90% of the stock is currently owned by insiders.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.